Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Die Onkologie
Erschienen in: Der Onkologe 2/2016

01.02.2016 | Prostatakarzinom | CME

Krebs und Lebensstil

Was hilft wirklich?

verfasst von: PD Dr. U. Seifart

Erschienen in: Die Onkologie | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die stetig wachsende Zahl an Patienten, die ihre Krebserkrankung überleben (Langzeitüberlebende), und deren spezielle Lebenssituationen bedingen einen zunehmenden Bedarf an Beratungen zu den Themen Lebensqualität und Rezidivprophylaxe. Diese Beratung ist häufig mit Aspekten der komplementären Medizin oder auch sozialmedizinischen Aspekten vergesellschaftet. In der Langzeitbetreuung von Patienten gewinnt sie zunehmend an Bedeutung. In diesem Beitrag werden die wissenschaftlich gesicherten Erkenntnisse zu den Aspekten Ernährung, Sport, Nikotinabusus und berufliche Wiedereingliederung („return to work“) sowie deren Bedeutung für den Verlauf einer Krebserkrankung dargestellt.
Literatur
1.
Fair AM, Montgomery K (2009) Energy balance, physical activity, and cancer risk. Methods Mol Biol 472:57–88CrossRefPubMed
2.
Holmes MD, Chen WY, Feskanich D et al (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486CrossRefPubMed
3.
Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128–1143
4.
Goodwin P (2006) Energy balance and cancer prognosis. In: McTiernan A (Hrsg) Cancer prevention and management through exercise and weight control. Taylor and Francis, Boca Raton, S 405
5.
Holick CN, Newcomb PA, Trentham-Dietz A et al (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17:379–386CrossRefPubMed
6.
Galvão DA, Newton RU (2005) Review of exercise intervention studies in cancer patients. J Clin Oncol 23:899
7.
Segal R, Pond GR, Vallis M et al (2011) Randomized trial of a lifestyle intervention for women with early-stage breast cancer (BC) receiving adjuvant hormone therapy: initial results. J Clin Oncol 29:2011 (Suppl; Abstract 512)
8.
Meyerhardt JA, Niedzwiecki D, Hollis D et al (2007) Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 298:754–764CrossRefPubMed
9.
Meyerhardt JA, Sato K, Niedzwiecki D et al (2012) Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 104:1702–1711
10.
Davies AA, Davey Smith G, Harbord R et al (2006) Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst 98:961–973
11.
Blanchard CM, Courneya KS, Stein K; American Cancer Society’s SCS-II (2008) Cancer survivors‘ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol 26:2198–2204
12.
Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302–3316
13.
Goodwin PJ, Ennis M, Pritchard KI et al (2003) Diet and breast cancer: evidence that extremes in diet are associated with poor survival. J Clin Oncol 21:2500–2507
14.
Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15CrossRefPubMed
15.
Chlebowski R, Blackburn G, Elashoff R et al (2006) Mature analysis from the Women’s Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome. San Antonio Breast Cancer Symposium. San Antonio, TX
16.
Pierce JP, Natarajan L, Caan BJ et al (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289–298PubMedCentralCrossRefPubMed
17.
Discacciati A, Orsini N, Wolk A (2012) Body mass index and incidence of localized and advanced prostate cancer – a dose-response meta-analysis of prospective studies. Ann Oncol 23:1665–1671CrossRefPubMed
18.
Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 105(Suppl 1):S52–S73PubMedCentralCrossRefPubMed
19.
Berkow SE, Barnard ND, Saxe GA, Ankerberg-Nobis T (2007) Diet and survival after prostate cancer diagnosis. Nutr Rev 65:391–403CrossRefPubMed
20.
Meyer F, Bairati I, Shadmani R et al (1999) Dietary fat and prostate cancer survival. Cancer Causes Control 10:245–251CrossRefPubMed
21.
Van Patten CL, Boer JG de, Tomlinson Guns ES (2008) Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol 180:2314–2321
22.
Demark-Wahnefried W, Polascik TJ, George SL et al (2008) Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 17:3577–3587PubMedCentralCrossRefPubMed
23.
Strom SS, Yamamura Y, Flores-Sandoval FN et al (2008) Prostate cancer in Mexican-Americans: identification of risk factors. Prostate 68:563–570CrossRefPubMed
24.
Ornish D, Weidner G, Fair WR et al (2005) Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174:1065–1070
25.
Frattaroli J, Weidner G, Dnistrian AM et al (2008) Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 72:1319–1323CrossRefPubMed
26.
Schmitz KH, Courneya KS, Matthews C et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426CrossRefPubMed
27.
Mishra SI, Scherer RW, Snyder C et al (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 8:CD008465PubMed
28.
Irwin ML, Smith AW, McTiernan A et al (2008) Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 26:3958
29.
Chen X, Lu W, Zheng W et al (2011) Exercise after diagnosis of breast cancer in association with survival. Cancer Prev Res (Phila) 4:1409–1418CrossRef
30.
Schmitz KH, Ahmed RL, Troxel A et al (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361:664–673
31.
Ballard-Barbash R, Friedenreich CM, Courneya KS et al (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104:815–840
32.
Lynch BM, Cerin E, Owen N et al (2008) Prospective relationships of physical activity with quality of life among colorectal cancer survivors. J Clin Oncol 26:4480–4487
33.
Peddle CJ, Au HJ, Courneya KS (2008) Associations between exercise, quality of life, and fatigue in colorectal cancer survivors. Dis Colon Rectum 51:1242–1248CrossRefPubMed
34.
Morey MC, Snyder DC, Sloane R et al (2009) Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA 301:1883–1891PubMedCentralCrossRefPubMed
35.
Buffart LM, Thong MS, Schep G et al (2012) Self-reported physical activity: its correlates and relationship with health-related quality of life in a large cohort of colorectal cancer survivors. PLoS One 7:e36164PubMedCentralCrossRefPubMed
36.
Arem H, Pfeiffer RM, Engels EA et al (2015) Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP Diet and Health Study. J Clin Oncol 33:180–188
37.
Van Blarigan EL, Myerhardt JA (2015) Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol 33(16):1825–1834
38.
Richman EL, Kenfield SA, Stampfer MJ et al (2011) Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71:3889–3895PubMedCentralCrossRefPubMed
39.
Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29:726–732
40.
Coups EJ, Ostroff JS (2005) A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med 40:702–711CrossRefPubMed
41.
US Department of Health and Human Services (2014) The health consequences of smoking – 50 years of progress: a report of the surgeon general. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
42.
Pytynia KB, Grant JR, Etzel CJ et al (2004) Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol 22:3981–3988
43.
Do KA, Johnson MM, Lee JJ et al (2004) Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101:2837–2842CrossRefPubMed
44.
Khuri FR, Kim ES, Lee JJ et al (2001) The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 10:823–829PubMed
45.
Browman GP, Wong G, Hodson I et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159–163
46.
Browman GP, Mohide EA, Willan A et al (2002) Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck 24:1031–1037CrossRefPubMed
47.
Garces YI, Schroeder DR, Nirelli LM et al (2004) Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis. Cancer 101:116–124CrossRefPubMed
48.
Hoff CM, Grau C, Overgaard J (2012) Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma – a prospective study. Radiother Oncol 103:38–44CrossRefPubMed
49.
Duffy SA, Ronis DL, McLean S et al (2009) Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 27:1969–1975
50.
Gillison ML, Zhang Q, Jordan R et al (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30:2102–2111
51.
Balduyck B, Sardari Nia P, Cogen A et al (2011) The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg 40:1432–1437PubMed
52.
Chen J, Qi Y, Wampfler JA et al (2012) Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer 48:1593–1601PubMedCentralCrossRefPubMed
53.
54.
Holmes MD, Murin S, Chen WY et al (2007) Smoking and survival after breast cancer diagnosis. Int J Cancer 120:2672–2677CrossRefPubMed
55.
Parsons A, Daley A, Begh R, Aveyard P (2010) Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 340:b5569PubMedCentralCrossRefPubMed
56.
Tucker MA, Murray N, Shaw EG et al (1997) Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 89:1782–1788
57.
S3-Leitlinie „Screening, Diagnostik und Behandlung des schädlichen und abhängigen Tabakkonsums. AWMF-Register Nr. 076-006. http://​www.​awmf.​org/​leitlinien/​detail/​ll/​076-006.​html.​ Zugegriffen: 30. November 2015
58.
Rick O, Kalusche EM, Dauelsberg T et al (2012) Reintegration von Krebspatienten ins Erwerbsleben. Dtsch Arztebl Int 109(42):702–708. doi: 10.3238/arztebl.2012.0702PubMedCentralPubMed
59.
Boer AG de, Taskila T, Ojajärvi A et al (2009) Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 301:753–762CrossRefPubMed
60.
Mehnert A (2011) Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 77:109–130CrossRefPubMed
61.
Kristinsson SY, Derolf AR, Edgren G et al (2009) Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden. J Clin Oncol 27:2073–2080
62.
Jansen L, Eberle A, Emrich K et al (2013) Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer 134:2951–2960CrossRefPubMed
Metadaten
Titel
Krebs und Lebensstil
Was hilft wirklich?
verfasst von
PD Dr. U. Seifart
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Onkologie / Ausgabe 2/2016
Print ISSN: 2731-7226
Elektronische ISSN: 2731-7234
DOI
https://doi.org/10.1007/s00761-016-0009-5

Weitere Artikel der Ausgabe 2/2016

Der Onkologe 2/2016 Zur Ausgabe

Leitthema

Risikogruppen mit einer erblichen Disposition für familiäre (polygene) kolorektale Karzinome

Leitthema

Chirurgische Therapie des Kolonkarzinoms

Algorithmus und Klassifikation

Algorithmus-Management des Kolonkarzinoms

Leitthema

Metastasiertes kolorektales Karzinom

Psychoonkologie

Bedarf, Kenntnis, Akzeptanz und Nutzung von psychosozialen Angeboten

Leitthema

Möglichkeiten der lokal-ablativen Bestrahlung (SBRT) bei metastasiertem kolorektalem Karzinom

Weitere Lesetipps

ANZEIGE

Spagat zwischen Leitlinien und klinischem Alltag

ANZEIGE

Sichere Antikoagulation bei ständig wechselnden Risikokonstellationen

Erhöhtes Keratitis-Risiko unter EGFR-Inhibitor-Therapie

CME: Evidenzbasierte Komplementärmedizin in der Urologie

Fortschritte in der zielgerichteten Behandlung des nicht-kleinzelligen Lungenkarzinoms

ANZEIGE

CAT-Management - Was gibt es Neues bei den NMH

Bildnachweise